Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Cappelli

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Seminars in Arthritis and Rheumatism|November 22, 2024
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?Laura C Cappelli
Current Opinion in Rheumatology|March 14, 2020
Treatment of immune checkpoint inhibitor-induced inflammatory arthritisSusanna Jeurling, Laura C Cappelli
Rheumatic Diseases Clinics of North America|November 19, 2017
Gastrointestinal and Hepatic Disease in Rheumatoid ArthritisEthan Craig, Laura C Cappelli
Best Practice & Research. Clinical Rheumatology|December 20, 2022
Treatment of rheumatic adverse events of cancer immunotherapyPankti Reid, Laura C Cappelli
Best Practice & Research. Clinical Rheumatology|February 8, 2020
The relationships between cancer and autoimmune rheumatic diseasesLaura C Cappelli, Ami A Shah
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2020
Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic ComplicationsLaura C Cappelli, Clifton O Bingham
Nature Reviews. Rheumatology|September 2, 2018
Rheumatic immune-related adverse events from cancer immunotherapyLeonard H Calabrese, Cassandra Calabrese, Laura C Cappelli
RMD Open|October 19, 2016
Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entitiesLaura C Cappelli, Ami A Shah, Clifton O Bingham
Rheumatic Diseases Clinics of North America|November 29, 2016
Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for RheumatologyLaura C Cappelli, Ami A Shah, Clifton O Bingham
Best Practice & Research. Clinical Rheumatology|May 5, 2026
The management of rheumatic immune related adverse eventsPankti Reid, Namrata Singh, Tawnie Braaten, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Seminars in Arthritis and Rheumatism|November 22, 2024
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?Laura C Cappelli
Current Opinion in Rheumatology|March 14, 2020
Treatment of immune checkpoint inhibitor-induced inflammatory arthritisSusanna Jeurling, Laura C Cappelli
Rheumatic Diseases Clinics of North America|November 19, 2017
Gastrointestinal and Hepatic Disease in Rheumatoid ArthritisEthan Craig, Laura C Cappelli
Best Practice & Research. Clinical Rheumatology|December 20, 2022
Treatment of rheumatic adverse events of cancer immunotherapyPankti Reid, Laura C Cappelli
Best Practice & Research. Clinical Rheumatology|February 8, 2020
The relationships between cancer and autoimmune rheumatic diseasesLaura C Cappelli, Ami A Shah
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2020
Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic ComplicationsLaura C Cappelli, Clifton O Bingham
Nature Reviews. Rheumatology|September 2, 2018
Rheumatic immune-related adverse events from cancer immunotherapyLeonard H Calabrese, Cassandra Calabrese, Laura C Cappelli
RMD Open|October 19, 2016
Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entitiesLaura C Cappelli, Ami A Shah, Clifton O Bingham
Rheumatic Diseases Clinics of North America|November 29, 2016
Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for RheumatologyLaura C Cappelli, Ami A Shah, Clifton O Bingham
Best Practice & Research. Clinical Rheumatology|May 5, 2026
The management of rheumatic immune related adverse eventsPankti Reid, Namrata Singh, Tawnie Braaten, et al.
Pageof 6